Paromomycin sulfate clinical pharmacology: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Paromomycin sulfate}} {{CMG}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PAROMOMYCIN SULFATE CAPSULE [CARACO PHARMACEUTICAL LAB...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Paromomycin sulfate}} | {{Paromomycin sulfate}} | ||
{{CMG}} | {{CMG}} | ||
==Clinical Pharmacology== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PAROMOMYCIN SULFATE CAPSULE [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22494bde-a53e-4b3c-a89b-0ccda341f28f | publisher = | date = | accessdate = }}</ref> | The in vitro and in vivo antibacterial action of paromomycin closely parallels that of neomycin. It is poorly absorbed after oral administration, with almost 100% of the drug recoverable in the stool.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PAROMOMYCIN SULFATE CAPSULE [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22494bde-a53e-4b3c-a89b-0ccda341f28f | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 20:38, 23 December 2013
| Paromomycin Sulfate |
|---|
| PAROMOMYCIN SULFATE capsule® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Clinical Pharmacology
The in vitro and in vivo antibacterial action of paromomycin closely parallels that of neomycin. It is poorly absorbed after oral administration, with almost 100% of the drug recoverable in the stool.[1]
References
Adapted from the FDA Package Insert.